Open Access

Perioperative detection of circulating tumour cells in patients with lung cancer

  • Authors:
    • Dimple Chudasama
    • Nathan Burnside
    • Julie Beeson
    • Emmanouil Karteris
    • Alexandra Rice
    • Vladimir Anikin
  • View Affiliations

  • Published online on: June 9, 2017     https://doi.org/10.3892/ol.2017.6366
  • Pages: 1281-1286
  • Copyright: © Chudasama et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is a leading cause of mortality and despite surgical resection a proportion of patients may develop metastatic spread. The detection of circulating tumour cells (CTCs) may allow for improved prediction of metastatic spread and survival. The current study evaluates the efficacy of the ScreenCell® filtration device, to capture, isolate and propagate CTCs in patients with primary lung cancer. Prior to assessment of CTCs, the present study detected cancer cells in a proof‑of‑principle‑ experiment using A549 human lung carcinoma cells as a model. Ten patients (five males and five females) with pathologically diagnosed primary non‑small cell lung cancer undergoing surgical resection, had their blood tested for CTCs. Samples were taken from a peripheral vessel at the baseline, from the pulmonary vein draining the lobe containing the tumour immediately prior to division, a further central sample was taken following completion of the resection, and a final peripheral sample was taken three days post‑resection. A significant increase in CTCs was observed from baseline levels following lung manipulation. No association was able to be made between increased levels of circulating tumour cells and survival or the development of metastatic deposits. Manipulation of the lung during surgical resection for non‑small cell lung carcinoma results in a temporarily increased level of CTCs; however, no clinical impact for this increase was observed. Overall, the study suggests the ScreenCell® device has the potential to be used as a CTC isolation tool, following further work, adaptations and improvements to the technology and validation of results.
View Figures
View References

Related Articles

Journal Cover

August-2017
Volume 14 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chudasama D, Burnside N, Beeson J, Karteris E, Rice A and Anikin V: Perioperative detection of circulating tumour cells in patients with lung cancer. Oncol Lett 14: 1281-1286, 2017
APA
Chudasama, D., Burnside, N., Beeson, J., Karteris, E., Rice, A., & Anikin, V. (2017). Perioperative detection of circulating tumour cells in patients with lung cancer. Oncology Letters, 14, 1281-1286. https://doi.org/10.3892/ol.2017.6366
MLA
Chudasama, D., Burnside, N., Beeson, J., Karteris, E., Rice, A., Anikin, V."Perioperative detection of circulating tumour cells in patients with lung cancer". Oncology Letters 14.2 (2017): 1281-1286.
Chicago
Chudasama, D., Burnside, N., Beeson, J., Karteris, E., Rice, A., Anikin, V."Perioperative detection of circulating tumour cells in patients with lung cancer". Oncology Letters 14, no. 2 (2017): 1281-1286. https://doi.org/10.3892/ol.2017.6366